Fructose bisphosphatase deficiency

Fructose bisphosphatase deficiency
Fructose 1,6-bisphosphate
ICD-10	E74.1
OMIM	229700
DiseasesDB	5012
eMedicine	ped/806
MeSH	D015319

WikiDoc Resources for Fructose bisphosphatase deficiency
Articles
Most recent articles on Fructose bisphosphatase deficiency Most cited articles on Fructose bisphosphatase deficiency Review articles on Fructose bisphosphatase deficiency Articles on Fructose bisphosphatase deficiency in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Fructose bisphosphatase deficiency Images of Fructose bisphosphatase deficiency Photos of Fructose bisphosphatase deficiency Podcasts & MP3s on Fructose bisphosphatase deficiency Videos on Fructose bisphosphatase deficiency
Evidence Based Medicine
Cochrane Collaboration on Fructose bisphosphatase deficiency Bandolier on Fructose bisphosphatase deficiency TRIP on Fructose bisphosphatase deficiency
Clinical Trials
Ongoing Trials on Fructose bisphosphatase deficiency at Clinical Trials.gov Trial results on Fructose bisphosphatase deficiency Clinical Trials on Fructose bisphosphatase deficiency at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Fructose bisphosphatase deficiency NICE Guidance on Fructose bisphosphatase deficiency NHS PRODIGY Guidance FDA on Fructose bisphosphatase deficiency CDC on Fructose bisphosphatase deficiency
Books
Books on Fructose bisphosphatase deficiency
News
Fructose bisphosphatase deficiency in the news Be alerted to news on Fructose bisphosphatase deficiency News trends on Fructose bisphosphatase deficiency
Commentary
Blogs on Fructose bisphosphatase deficiency
Definitions
Definitions of Fructose bisphosphatase deficiency
Patient Resources / Community
Patient resources on Fructose bisphosphatase deficiency Discussion groups on Fructose bisphosphatase deficiency Patient Handouts on Fructose bisphosphatase deficiency Directions to Hospitals Treating Fructose bisphosphatase deficiency Risk calculators and risk factors for Fructose bisphosphatase deficiency
Healthcare Provider Resources
Symptoms of Fructose bisphosphatase deficiency Causes & Risk Factors for Fructose bisphosphatase deficiency Diagnostic studies for Fructose bisphosphatase deficiency Treatment of Fructose bisphosphatase deficiency
Continuing Medical Education (CME)
CME Programs on Fructose bisphosphatase deficiency
International
Fructose bisphosphatase deficiency en Espanol Fructose bisphosphatase deficiency en Francais
Business
Fructose bisphosphatase deficiency in the Marketplace Patents on Fructose bisphosphatase deficiency
Experimental / Informatics
List of terms related to Fructose bisphosphatase deficiency

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

In Fructose bisphosphatase deficiency, there is not enough fructose bisphosphatase for gluconeogenesis to occur correctly. Glycolysis (the break-down of glucose) will still work, as it does not use this enzyme.

Presentation

Without effective gluconeogenesis (GNG), hypoglycaemia will set in after about 12 hours. This is the time when liver glycogen stores have been exhausted, and the body has to rely on GNG. When given a dose of glucagon (which would normally increase blood glucose) nothing will happen, as stores are depleted and GNG doesn't work. (In fact, the patient would already have high glucagon levels.)

There is no problem with the metabolism of glucose or galactose, but fructose and glycerol cannot be used as fuels. If fructose or glycerol are given, there will be a build up of phosphorylated three-carbon sugars. This leads to phosphate depletion within the cells, and also in the blood. Without phosphate, ATP cannot be made, and many cell processes cannot occur.

High levels of glucagon will tend to release fatty acids from adipose tissue, and this will combine with glycerol that cannot be used in the liver, to make triacylglycerides causing a fatty liver.

As three carbon molecules cannot be used to make glucose, the will instead be made into pyruvate and lactate. These acids cause a drop in the pH of the blood (a metabolic acidosis). Acetyl CoA (acetyl co-enzyme A) will also build up, leading to the creation of ketone bodies.

Treatment

To treat people with a deficiency of this enzyme, they must avoid needing gluconeogenesis to make glucose. This can be accomplished by not fasting for long periods, and eating high-carbohydrate food. They should avoid fructose containing foods (as well as sucrose which breaks down to fructose).

As with all single-gene metabolic disorders, there is always hope for genetic therapy, inserting a healthy copy of the gene into existing liver cells.

See also

• Fructose
• Gluconeogenesis
• Metabolism

References

• diMauro, Salvatore (1998). "Diseases of Carbohydrate, Fatty Acid and Mitochondrial Metabolism". In George J. Siegel et al (ed.). Basic Neurochemistry: Molecular, Cellular and Medical Aspects (6th Edition ed.). Philadelphia, Pennsylvania: Lippincott Williams and Wilkins. ISBN 0-7817-1745-0. CS1 maint: Extra text: editors list (link) CS1 maint: Extra text (link)